About EuroVacc

EuroVacc Foundation is a non-profit organization created in 2002, building on the research program “European Vaccine Effort Against HIV/AIDS” funded by the European Commission.

EuroVacc’s core activity

EuroVacc’s core activity is to facilitate the development of vaccine candidates through early clinical trials, to enable early identification of the promising vaccine candidates and eliminate candidates unlikely to succeed in the clinic, with the ultimate goal to reduce the development risks and accelerate the advancement of the promising candidates to large clinical trials.

EuroVacc’s primary objectives

Promote vaccine research

To promote vaccine research against HIV and other infectious diseases by bridging the strength of academic research groups with industrial expertise

Facilitate and support phase I & II clinical trials in Europe

To facilitate and support phase I & II clinical trials in Europe to expedite translational research from discovery to clinical development;

Partner with other international initiative

To partner with other international initiatives and industry for down-stream development and phase IIb/III trials.

EuroVacc Board

The governing body of the EuroVacc Foundation is the Board of Directors, responsible for the programmatic and financial management.

International Collaborations

Promoting collaboration with international stakeholders in the HIV and other infectious diseases fields is a central theme in EuroVacc’s mission, in order to broaden the discovery program and advance the product and clinical development of the most promising vaccine candidates.